- Aggressiveness and efficacy of 131I therapy in papillary thyroid carcer with peripheral nerve invasion: a propensity score matching studyXiong, X.Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, AUSTRIA, 2023-09-09 To 2023-09-13.
- High Ki-67 LI is an Important Factor for Good Early Outcomes After Radioiodine Therapy in Patients with Intermediate to High-Risk Papillary Thyroid CancerLuo, X.; Ouyang, W.Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, AUSTRIA, 2023-09-09 To 2023-09-13.
- LIBRETTO-321, a phase II study of the efficacy and safety of selpercatinib in Chinese patients with advanced RET-altered thyroid cancer (TC)Zheng, X.; Ji, Q.; Sun, Y.; Ge, M.; Zhang, B.; Cheng, Y.; Lei, S.; Shi, F.; Zhang, W.; Gao, M.ESMO Targeted Anticancer Therapies Congress (TAT), ELECTR NETWORK, 2022-03-07 To 2022-03-08.被引 1
期刊论文
Hear the Patient's Voice Regarding Implementation of Thyroid Cancer Active Surveillance in China
5阅读
